The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Comparing my trajectory with the trial curves, carefully

This is a generated summary. It shows the 9 most-liked posts from a topic of 93, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
W
WoodhouseTL2Member Solution10 May 2025#4
ca.vermeulen, post #3: Picking up post #2: that is the part I would want checked first. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady, accelerating, or stalling. Go to post

Coming back to post #3, because the follow-up matters more than the original answer.

Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that scale-based weight misses.

7 likes in reply to #3 15mo
ON
o.nybergTL2 Moderator22 May 2025#7
ca.vermeulen, post #3: Picking up post #2: that is the part I would want checked first. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady, accelerating, or stalling. Go to post

Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when weighing reduces apparent noise.

29 likes in reply to #3 14mo
RS
r.scholtenTL2Member2 Jun 2025#10

On post #6 — agreed on the reasoning, with one qualification.

Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes the record interpretable.

28 likes 14mo
LS
l.sarkissianTL2Member21 Jun 2025#16

This follows post #13 rather than contradicting it.

Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is still working either. It is a data point in a longer record.

29 likes 13mo
V
VThorvaldsenTL3Regular14 Jul 2025#24

On post #20 — agreed on the reasoning, with one qualification.

Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than accuracy at capturing absolute weight.

29 likes 12mo
RZ
ro.zielinskiTL2 Moderator15 Aug 2025#36

post #35 is right about the mechanism and I think understates the practical bit.

Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady, accelerating, or stalling.

28 likes 11mo
CN
c.niemelTL3Regular2 Oct 2025#56

Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is still working either. It is a data point in a longer record.

31 likes 10mo
MD
m.dalgaardTL3Regular20 Oct 2025#64

Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes the record interpretable.

27 likes 9mo
ST
s.teixeiraTL2 Moderator31 Oct 2025#69

Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is still working either. It is a data point in a longer record.

29 likes 9mo

Read the full topic (93 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Reporting a disappointing outcome, and why it belongs here
Reporting a disappointing outcome, and why it belongs here Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a number…
SSMOPPSDEV+21 29 62k 10mo
What I would record differently if I started again
Asking directly, because I could not find a straight answer: What I would record differently if I started again Maintenance rather than loss, which is the part of this that almost nobody writes about. I have…
MICLVK 2 12k 5mo
What I would record differently if I started again — the long version
What I would record differently if I started again — the long version I have a specific reason for asking rather than idle curiosity, and the context is below. Maintenance rather than loss, which is the part…
VMHMRLEVLO+22 26 57k 5mo
An 18-month record including the parts that went badly
An 18-month record including the parts that went badly — setting out what I have, and where I think it stops being reliable. Longitudinal report with the method stated, because a number without a method is…
POBWBEPDED+77 81 17k 12h
[2026 update] Waist circumference technique and its repeatability
Posting this under the heading it deserves: Waist circumference technique and its repeatability Everything below is what sits behind that. Longitudinal report with the method stated, because a number without…
RZZACNSKG+23 27 5.9k 21h

Related topics — sharing the tags DXA, effect size, long read

TopicParticipantsRepliesViewsActivity
Pen wastage and its effect on real cost
Pen wastage and its effect on real cost Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what determines…
WVGPFYWMG+29 33 19k 21mo
Citing a preprint in a maintained document: our rule and its reasoning
On the subject in the title: Citing a preprint in a maintained document: our rule and its reasoning Working notes rather than a conclusion. I have seen SELECT ( N Engl J Med , 2023) cited in support of a…
OVSLTN 2 467 4mo
Measurement error in a self-reported exposure
Posting this under the heading it deserves: Measurement error in a self-reported exposure Everything below is what sits behind that. Session topic: SURPASS-2 ( N Engl J Med , 2021). Please read it before…
LHCKSVCW+117 129 45k 5mo
Journal club: PIONEER 6 as a safety trial
Posting this under the heading it deserves: Journal club: PIONEER 6 as a safety trial Everything below is what sits behind that. Session topic: SURMOUNT-4 ( JAMA , 2024). Please read it before posting; the…
SCMONMWSH+14 18 262 5mo
Vagal afferents and the gut-brain pathway — one year on
Vagal afferents and the gut-brain pathway — one year on Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical one. I have a…
AKTLAW 2 136 11mo